Events Partner Content 2nd Annual Next Generation Pharmaceutical Cleanrooms Confere... Next Gen Pharma Cleanrooms
Events Partner Content SMi’s 5th Annual Pharmaceutical Microbiology East Coast Conf... Pharmaceutical Microbiology East Coast
Partner Content Partner Content Exclusive Pharma Microbiology interview with Maria Jose Lope... Exclusive Microbiology interview with Maria Barragan
Partner Content Partner Content Pharma Microbiology East Coast Conference - A Virtual Confer... Pharma Microbiology East Coast a Virtual Conference
Partner Content Partner Content Exclusive Interview Matts Ramstorp Chair for SMi's Next Gene... Exclusive Interview Matts Ramstorp Chair Cleanroom Conf
Partner Content Partner Content Conference Chair invitation letter for SMi’s Pharmaceutical ... Chair invite to Pharma Microbiology
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.